|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.88 EUR | 0.00% |
|
-2.04% | -21.53% |
| Mar. 26 | Atrys Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Atrys Health, S.A. announced that it has received ?13.3 million in funding | CI |
Atrys Health, S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 191.83 million compared to EUR 123.85 million a year ago. Revenue was EUR 193.14 million compared to EUR 127.84 million a year ago.
Net loss was EUR 23.26 million compared to EUR 23.26 million a year ago. Basic loss per share was EUR 0.341 compared to EUR 0.462 a year ago. Diluted loss per share was EUR 0.341 compared to EUR 0.462 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.53% | 233M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +11.62% | 29.59B | |
| -12.71% | 16.73B | |
| -2.46% | 16.36B | |
| -2.63% | 14.92B | |
| -31.40% | 11.77B | |
| -0.61% | 11.72B | |
| +27.44% | 11.71B |
ATRYS HEALTH, S.A. 
